GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nirvana Life Sciences Inc (XCNQ:NIRV) » Definitions » Quick Ratio

Nirvana Life Sciences (XCNQ:NIRV) Quick Ratio : 0.05 (As of Jan. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Nirvana Life Sciences Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Nirvana Life Sciences's quick ratio for the quarter that ended in Jan. 2024 was 0.05.

Nirvana Life Sciences has a quick ratio of 0.05. It indicates that the company cannot currently fully pay back its current liabilities.

The historical rank and industry rank for Nirvana Life Sciences's Quick Ratio or its related term are showing as below:

XCNQ:NIRV' s Quick Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.07   Max: 0.97
Current: 0.05

During the past 6 years, Nirvana Life Sciences's highest Quick Ratio was 0.97. The lowest was 0.01. And the median was 0.07.

XCNQ:NIRV's Quick Ratio is not ranked
in the Biotechnology industry.
Industry Median: 3.5 vs XCNQ:NIRV: 0.05

Nirvana Life Sciences Quick Ratio Historical Data

The historical data trend for Nirvana Life Sciences's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nirvana Life Sciences Quick Ratio Chart

Nirvana Life Sciences Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Apr22 Apr23
Quick Ratio
Get a 7-Day Free Trial 0.01 - 0.97 0.22 0.07

Nirvana Life Sciences Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 0.07 0.11 0.07 0.05

Competitive Comparison of Nirvana Life Sciences's Quick Ratio

For the Biotechnology subindustry, Nirvana Life Sciences's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nirvana Life Sciences's Quick Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nirvana Life Sciences's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Nirvana Life Sciences's Quick Ratio falls into.



Nirvana Life Sciences Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Nirvana Life Sciences's Quick Ratio for the fiscal year that ended in Apr. 2023 is calculated as

Quick Ratio (A: Apr. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(0.069-0)/1.008
=0.07

Nirvana Life Sciences's Quick Ratio for the quarter that ended in Jan. 2024 is calculated as

Quick Ratio (Q: Jan. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(0.049-0)/1.029
=0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nirvana Life Sciences  (XCNQ:NIRV) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Nirvana Life Sciences Quick Ratio Related Terms

Thank you for viewing the detailed overview of Nirvana Life Sciences's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Nirvana Life Sciences Business Description

Traded in Other Exchanges
N/A
Address
650 West Georgia Street, Suite 2110, Vancouver, BC, CAN, V6B 4N8
Nirvana Life Sciences Inc is focused on developing medical products and regimens that address addiction. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.

Nirvana Life Sciences Headlines

No Headlines